Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/1999
12/09/1999WO1999062539A1 Lysine containing peptides for treatment of heart disease
12/09/1999DE19826442A1 Rational designte Peptide, ihre Herstellung und ihre Verwendung Rational designed peptides, their preparation and their use
12/09/1999CA2330567A1 Lysine containing peptides for treatment of heart disease
12/09/1999CA2299389A1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/08/1999EP0962774A1 Detection of antibodies to FIV using ENV/GAG polypeptides
12/08/1999EP0962465A1 Methods of cyclisation of penta- and hexapeptides
12/08/1999EP0824545B1 Peptide compositions with growth factor-like activity
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0640101B1 Methods and reagents for diagnosis of autoantibodies
12/08/1999CN1237979A Conformationally constrained LH-RH analogues, their ues and pharmaceutical composisions containing them
12/08/1999CN1237896A Cosmetic preparation with peptide addition
12/07/1999US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999US5998577 Method for determining mimotopes
12/07/1999US5998140 Complexes of cell with oligomer
12/07/1999US5997870 Isolated peptides which bind to HLA-B44 Molecules
12/07/1999US5997845 Technetium-99M labeled peptides for imaging inflammation
12/07/1999CA2020663C Substitution analogues of magainin peptides
12/07/1999CA2004991C Deletion analogues of magainin peptides
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061613A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999WO1999061055A1 Bifunctional molecules and therapies based thereon
12/02/1999WO1999061041A1 Novel peptides
12/02/1999WO1999051725A3 Assay for the diagnosis of schizophrenia based on a new peptide
12/02/1999WO1999050281A3 Collagen peptides and uses thereof
12/02/1999WO1999049059A3 Methods of cancer diagnosis using a chimeric toxin
12/02/1999DE19824449A1 Verfahren zur Cyclisierung von Penta- und Hexapeptiden Procedure for the cyclization of penta- and hexapeptides
12/02/1999DE19823747A1 New pivaloyl-oxirane or diol derivatives, used as photolabile linkers for solid phase synthesis in combinatorial chemistry
12/02/1999CA2343317A1 Novel peptides
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2330611A1 Bifunctional molecules and therapies based thereon
12/02/1999CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/01/1999EP0960886A1 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
12/01/1999EP0960885A1 Depsipeptides and drugs containing the same as the active ingredient
12/01/1999EP0960122A1 Myelopeptides and their therapeutic use
12/01/1999EP0960119A1 T cell antigen receptor peptides
12/01/1999EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
12/01/1999EP0833646B1 Multi-tyrosinated somatostatin analogs
11/1999
11/30/1999US5994502 Inhibitors of oligosaccharyl transferase
11/30/1999US5994313 Regulated apoptosis
11/30/1999US5994307 Human t-cell lymphoma virus
11/30/1999US5994306 Fine-tuned protegrins
11/30/1999US5994299 Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them
11/30/1999US5994114 A polynucleotide which codes for a protein having taxadiene synthase activity; chemotherapy
11/30/1999US5994109 Nucleic acid transporter system and methods of use
11/30/1999US5994083 Collect serum samples from infected pateints with antibodies and a healthy individual, identify antibodies which bind antigens specific to the disease from phage library; select phages that display antigen recognized by antibody; vaccines
11/30/1999US5993775 Peptides which bind technetium or rhenium and which can be targeted to specific sites within a mammalian body.
11/30/1999CA2030795C Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
11/25/1999WO1999060134A1 New peptide fragments for protein purification
11/25/1999WO1999060018A1 Labelled glutamine and lysine analogues
11/25/1999WO1999060016A2 Antimicrobial cationic peptide derivatives of bactenecin
11/25/1999WO1999059631A1 Prevention and treatment of hypergastrinemia
11/25/1999WO1999059615A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999WO1999059412A1 Biocontrol agent and pesticide
11/25/1999WO1999051051A3 A method for controlling connections to a mobile station
11/25/1999WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
11/25/1999CA2690399A1 Il-6 antagonist peptides
11/25/1999CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999CA2332277A1 Labelled glutamine and lysine analogues
11/25/1999CA2328501A1 Prevention and treatment of hypergastrinemia
11/24/1999EP0959079A1 Vaccine for the reversible immunocastration of mammals
11/24/1999EP0959078A1 Peptides, methods for assaying human pepsinogen i or human pepsin i, and assay kits
11/24/1999EP0958305A2 Inhibitions of the interaction between p53 and mdm2
11/24/1999EP0958283A1 New compounds with hemoregulating effect
11/24/1999EP0833653A4 Serum immunoregulatory polypeptides and uses therefor
11/24/1999CN1236010A Method for giving resistance to weed control compounds to plants
11/24/1999CN1046775C Dye transfer inhibition
11/23/1999US5990274 Cyclosporine derivatives and uses thereof
11/23/1999US5990273 Synthesis of cyclic peptides
11/23/1999US5989838 Immunological methods of detecting MN proteins and MN polypeptides
11/20/1999CA2238289A1 Biocontrol agent and fungicide for blackleg disease
11/18/1999WO1999058564A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999WO1999058162A2 Pharmaceuticals for the imaging of angiogenic disorders
11/18/1999WO1999058161A1 Intramolecularly-quenched near infrared fluorescent probes
11/18/1999WO1999058141A1 Indolicidin analogs and methods of using same
11/18/1999WO1999058140A1 Methods to increase white blood cell survival after chemotherapy
11/18/1999WO1999046284A9 Molecules that home to various selected organs or tissues
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2325659A1 Indolicidin analogs and methods of using same
11/18/1999CA2324555A1 Pharmaceuticals for the imaging of angiogenic disorders
11/17/1999EP0956297A1 Chiral peptide nucleic acids
11/17/1999EP0956296A2 Somatostatin antagonists
11/17/1999EP0956292A1 Conantokins
11/17/1999EP0956033A1 Total synthesis of the amino hip analogue of didemnin a
11/17/1999EP0956029A1 Cyclic peptides having broad spectrum antimicrobial activity
11/17/1999EP0792886B1 Novel peptide and therapeutic agent
11/17/1999EP0779895B1 An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
11/17/1999EP0651762B1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986049 Purification by applying a biological fluid to polypeptide support,washing, elution, fractionation and accumulation
11/16/1999US5985837 Cell growth inhibitor peptides; treating cancer in a mammal
11/16/1999US5985836 Alpha-1 proteinase inhibitor binding peptides
11/16/1999US5985835 Desmopressin for nocturia, incontinence and enuresis
11/16/1999US5985834 Nova- and decapeptides in the preparation of a drug for the treatment of aids
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985606 Human preprotachykinin B